people personality fears stress

COVID-19 Is Causing Shortages of Common Antidepressant Zoloft

Reading now: 651

The latest: According to a recent Food and Drug Administration (FDA) report, manufacturers are reporting shortages of sertraline (brand name Zoloft).

There are five companies on the shortage list that make the popular antidepressant, which is used to treat depression and anxiety.

Four of the five manufacturers are experiencing shortages on one or more of its sertraline formulations due to increased demand or shortages of active ingredients during COVID-19. The frontlines: Since the start of the COVID-19 pandemic, many people experienced a spike in mental health symptoms, including depression and anxiety.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles